BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12097462)

  • 41. Chemotherapy and uptake of technetium-99m sestamibi in breast cancer.
    Derebek E
    Eur J Nucl Med; 1998 Apr; 25(4):448. PubMed ID: 9643975
    [No Abstract]   [Full Text] [Related]  

  • 42. Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging: a comparative study.
    Brem RF; Fishman M; Rapelyea JA
    Acad Radiol; 2007 Aug; 14(8):945-50. PubMed ID: 17659240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utility and reproducibility of semiquantitative analysis of sestamibi breast images.
    Dunnwald LK; Hartnett SD; Mankoff DA
    J Nucl Med Technol; 1997 Jun; 25(2):106-9. PubMed ID: 9239613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
    Servais F; Blocklet DC; Seret AE; Lenaers A; Schoutens AC
    Radiology; 1997 Oct; 205(1):283; author reply 285-6. PubMed ID: 9315001
    [No Abstract]   [Full Text] [Related]  

  • 45. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
    Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
    Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Double-phase 99mTc-sestamibi scintimammography and trans-scan in diagnosing breast cancer.
    Melloul M; Paz A; Ohana G; Laver O; Michalevich D; Koren R; Wolloch Y; Gal R
    J Nucl Med; 1999 Mar; 40(3):376-80. PubMed ID: 10086698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Complementary scintigraphic examinations (99mTc-MDP, 99mTc-MIBI and Octreoscan) in breast neoplasm assessment].
    Stefănescu C; Chossiere L; Rusu V; Meignan M
    Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):165-8. PubMed ID: 9455458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast.
    Rhodes DJ; O'Connor MK; Phillips SW; Smith RL; Collins DA
    Mayo Clin Proc; 2005 Jan; 80(1):24-30. PubMed ID: 15667025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of technetium-99m sestamibi to indicate breast cancer invasiveness.
    Bourgeois P
    Eur J Nucl Med; 1995 Jun; 22(6):581-5. PubMed ID: 7556307
    [No Abstract]   [Full Text] [Related]  

  • 50. Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study.
    Hruska CB; Hunt KN; Conners AL; Geske JR; Brandt KR; Degnim AC; Vachon CM; O'Connor MK; Rhodes DJ
    Breast Cancer Res; 2019 Mar; 21(1):38. PubMed ID: 30850011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of Compton background and breast compression on cancer detection in scintimammography.
    Pani R; Scopinaro F; Pellegrini R; Soluri A; Weinberg IN; De Vincentis G
    Anticancer Res; 1997; 17(3B):1645-9. PubMed ID: 9179211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 99mTc-sestaMIBI breast scintigraphy.
    Colella AC; Scopinaro F; Schillaci O; Danieli R; De Vincentis G; Ierardi M; Tavolaro R
    Tumori; 1997; 83(2):520-2. PubMed ID: 9226008
    [No Abstract]   [Full Text] [Related]  

  • 53. Detection of occult breast carcinoma during evaluation of a skeletal tumor by Tc-99m MIBI scintigraphy.
    Hod N; Mindlin L; Horne T
    Isr Med Assoc J; 2003 Apr; 5(4):296-7. PubMed ID: 14509141
    [No Abstract]   [Full Text] [Related]  

  • 54. [Differentiation of benign and malignant palpable breast masses using 99mTc-MIBI imaging].
    He J; Li Y; Su J
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):226-8. PubMed ID: 9868120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography.
    Tiling R; Kessler M; Untch M; Sommer H; Linke R; Hahn K
    Eur J Radiol; 2005 Feb; 53(2):206-12. PubMed ID: 15664284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of Tc-99m THY and Tc-99m MIBI scans for diagnosis of breast lesions.
    Gutfilen B; Fonseca LM
    J Exp Clin Cancer Res; 2001 Sep; 20(3):385-91. PubMed ID: 11718219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of 99mTc-(V)-DMSA in breast imaging.
    Papantoniou V
    Eur J Nucl Med; 1998 May; 25(5):547. PubMed ID: 9669884
    [No Abstract]   [Full Text] [Related]  

  • 58. Breast Imaging Utilizing Dedicated Gamma Camera and (99m)Tc-MIBI: Experience at the Tel Aviv Medical Center and Review of the Literature Breast Imaging.
    Even-Sapir E; Golan O; Menes T; Weinstein Y; Lerman H
    Semin Nucl Med; 2016 Jul; 46(4):286-93. PubMed ID: 27237439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical significance of 99mTc-MIBI breast imaging in the diagnosis of early breast cancer.
    Ren C; Jin S; Zhou Q; Zhu H; Wang H; Liang C
    Asian J Surg; 2002 Apr; 25(2):126-9. PubMed ID: 12376231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary osteogenic sarcoma of breast detected on Tc-99m MIBI scintigraphy and Tc-99m MDP skeletal scintigraphy.
    Yang JG; Li CL; Hao RR; Zou LF
    Ann Nucl Med; 2008 Jan; 22(1):79-82. PubMed ID: 18250991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.